1-20 of 34
Raya Mawad
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fractionated gemtuzumab ozogamicin (GO) with high-dose cytarabine (HiDAC) based induction chemotherapy is safe and highly effective for newly diagnosed favorable risk AML.

Free
Brenda Castillo, Jacob Appelbaum, Megan Othus, Katie Russell, Rutu Vyas, Paul Hendrie, Anna Halpern, Cristina Maria Ghiuzeli, Ryan Cassaday, Raya Mawad, Mary-Elizabeth Percival, Roland Walter
Journal: Blood
Blood (2025) 146 (Supplement 1): 3378.
https://doi.org/10.1182/blood-2025-3378
Published: 2025
Journal Articles

Concurrent use of nucleoside reverse transcriptase inhibitors and purine analogs is associated with worse survival for patients with myeloid neoplasms: A single-center retrospective analysis

Free
Jason Gilbert, Megan Othus, Suravi Raychaudhuri, Katie Russell, Carole Shaw, Rutu Vyas, Anna Halpern, Paul Hendrie, Raya Mawad, Cristina Maria Ghiuzeli, Ryan Cassaday, Roland Walter, Emily Ford, Jacob Appelbaum, Mary-Elizabeth Percival
Journal: Blood
Blood (2025) 146 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2025-1677
Published: 2025
Journal Articles

A randomized phase 2 trial of CPX-351 vs. CLAG-m (Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone) in medically less-fit adults with previously untreated acute myeloid leukemia (AML) or other high-grade myeloid neoplasms

Free
Anna Halpern, Megan Othus, Mary-Elizabeth Percival, Cristina Maria Ghiuzeli, Jacob Appelbaum, Paul Hendrie, Ryan Cassaday, Bart Scott, Jason Cooper, Sioban Keel, Vivian Oehler, Johnnie Orozco, Katie Russell, Raya Mawad, Roland Walter
Journal: Blood
Blood (2025) 146 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2025-1663
Published: 2025
Journal Articles

Pivekimab sunirinine (PVEK) combined with FLAG-IDA for medically fit adults with untreated adverse-risk Acute Myeloid Leukemia (AML) or other high-grade myeloid neoplasms (NCT06034470)

Free
Jacob Appelbaum, Suravi Raychaudhuri, Katie Russell, Kimberly Cadiz, Stacey Fuller, Anna Halpern, Cristina Maria Ghiuzeli, Raya Mawad, Vivian Oehler, Ryan Cassaday, Jason Cooper, Paul Hendrie, Megan Othus, Mary-Elizabeth Percival, Roland Walter
Journal: Blood
Blood (2025) 146 (Supplement 1): 3422.
https://doi.org/10.1182/blood-2025-3422
Published: 2025
Journal Articles

Treatment intensity and transplant independently predict survival in TP53-mutated myeloid neoplasms: A large retrospective cohort study of clinical and genomic factors

Free
Sarah Peterson, Megan Othus, Katie Russell, Carole Shaw, Rutu Vyas, Anna Halpern, Cristina Maria Ghiuzeli, Paul Hendrie, Ryan Cassaday, Raya Mawad, Roland Walter, Jacob Appelbaum, Mary-Elizabeth Percival
Journal: Blood
Blood (2025) 146 (Supplement 1): 5265.
https://doi.org/10.1182/blood-2025-5265
Published: 2025
Journal Articles

Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) yields durable remissions and survival in adults with newly diagnosed acute lymphoblastic leukemia/lymphoma (ALL): Long-term follow-up of a prospective trial

Free
Mitin Nachu, Philip Stevenson, Kim Quach, Christen Martino, Mary-Elizabeth Percival, Anna Halpern, Pamela Becker, Vivian Oehler, Jason P. Cooper, Johnnie Orozco, Paul Hendrie, Roland Walter, Cristina Maria Ghiuzeli, Raya Mawad, Ryan Cassaday
Journal: Blood
Blood (2025) 146 (Supplement 1): 5128.
https://doi.org/10.1182/blood-2025-5128
Published: 2025
Journal Articles

Clinical features and outcomes of acquired versus baseline TP53 mutations in myeloid neoplasms: A single-center retrospective analysis

Free
Jason Gilbert, Megan Othus, Suravi Raychaudhuri, Katie Russell, Carole Shaw, Rutu Vyas, Anna Halpern, Paul Hendrie, Raya Mawad, Cristina Maria Ghiuzeli, Ryan Cassaday, Roland Walter, Jacob Appelbaum, Mary-Elizabeth Percival
Journal: Blood
Blood (2025) 146 (Supplement 1): 7022.
https://doi.org/10.1182/blood-2025-7022
Published: 2025
Journal Articles

CLAG-M or FLAG-Ida Followed Immediately By Allogeneic Hematopoietic Cell Transplantation for Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm

Free
Filippo Milano, Brenda M. Sandmaier, Mary-Elizabeth M. Percival, Sarah M Mahan, Laura C Roberts, Raya Mawad, Anna B. Halpern, Madi Brunette, Cristina Maria Ghiuzeli, Jacob S. Appelbaum, Naveed Ali, Roland B. Walter
Journal: Blood
Blood (2024) 144 (Supplement 1): 265.
https://doi.org/10.1182/blood-2024-209035
Published: 2024
Journal Articles

Results from the Completed Dose Escalation Portion of the Phase 1 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC®) Targeting B Cell Maturation Antigen (BCMA) for Relapsed/Refractory Multiple Myeloma (MM)

Free
Sumit Madan, Caitlin L. Costello, Brea Lipe, Andrew J. Cowan, Eva Medvedova, Jens Hillengass, P. Leif Bergsagel, Xavier Leleu, Cyrille Touzeau, Daniel Morillo, Albert Oriol, Raya Mawad, Henning Schade, Salomon Manier, Yifah Yaron, Banmeet Anand, Al-Ola Abdallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 1012.
https://doi.org/10.1182/blood-2023-182345
Published: 2023
Journal Articles

Treatment Outcomes for Adults with Mixed Phenotypic Acute Leukemia: A Large Single-Center Retrospective Study

Free
Jennifer J. Huang, Jacob S. Appelbaum, Kathryn Russell, Carole Shaw, Ashley M. Eckel, Xueyan Chen, Rutu D. Vyas, Paul C. Hendrie, Anna B. Halpern, Raya Mawad, Ryan D Cassaday, Roland B. Walter, Mary-Elizabeth M. Percival, Cristina Maria Ghiuzeli
Journal: Blood
Blood (2023) 142 (Supplement 1): 2838.
https://doi.org/10.1182/blood-2023-188461
Published: 2023
Journal Articles

Updated Interim Results from a Phase 1 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC®) Targeting B Cell Maturation Antigen (BCMA) for Relapsed/Refractory Multiple Myeloma (RRMM)

Free
Al-Ola Abdallah, Andrew J Cowan, Xavier Leleu, Cyrille Touzeau, Brea Lipe, Eva Medvedova, Caitlin Costello, Jens Hillengass, P. Leif Bergsagel, Raya Mawad, Henning Schade, Daniel Morillo Giles, Albert Oriol, Yifah Yaron, Patrick P Ng, Sumit Madan
Journal: Blood
Blood (2022) 140 (Supplement 1): 7284–7285.
https://doi.org/10.1182/blood-2022-159665
Published: 2022
Journal Articles

Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Neil Bailey, Tori Braun, Megumi Bailey, Tenzin Tsomo, Jennie Szeto, Sandra Benitez Kruidenier, Vanessa Dunleavy, Joanna Fesler, Gayle Funk, Sonia Glennie, Judson Hall, Julia Parker, Daniel Egan, Raya Mawad, Carol A Dean, Suzan Sullivan, Chia Lu, Heidi Hohmann, Jordan Briggs, Krish Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3765–3766.
https://doi.org/10.1182/blood-2022-164823
Published: 2022
Journal Articles

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Free
Naresh Bumma, Joshua Richter, Jason Brayer, Jeffrey A. Zonder, Madhav Dhodapkar, Mansi R. Shah, James E. Hoffman, Raya Mawad, Joseph J. Maly, Suzanne Lentzsch, Attaya Suvannasankha, Pourab Roy, Jyotirmoy Dey, Dhruti Chokshi, Anita Boyapati, Jenn Visich, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 10140–10141.
https://doi.org/10.1182/blood-2022-159969
Published: 2022
Journal Articles

Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Neil Bailey, Tenzin Tsomo, Tori Braun, Jennie Szeto, William I. Bensinger, Daniel Egan, Raya Mawad, Livia Hegerova, Gayle Funk, Joanna Fesler, Sonia Glennie, Judson Hall, Vanessa Dunleavy, Heidi Hohmann, Jordan Briggs, Joshua Mark, Megumi Bailey, John M. Pagel, Krish Patel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4554.
https://doi.org/10.1182/blood-2021-148505
Published: 2021
Journal Articles

Phase 1/2 Study Investigating CC-90011, a Potent, Selective, and Reversible Oral Inhibitor of Lysine-Specific Demethylase 1 (LSD1), Plus Concurrent Venetoclax (VEN) and Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML)

Free
Courtney D. DiNardo, Gautam Borthakur, Brian Ball, Harry P. Erba, Raya Mawad, Marina Kremyanskaya, James S. Blachly, Hetty E. Carraway, Ahrim Youn, Jessica Garzon, Daniel Lopes de Menezes, Patricia Martin-Regueira, C.L. Beach, Justin Watts
Journal: Blood
Blood (2021) 138 (Supplement 1): 4430.
https://doi.org/10.1182/blood-2021-146791
Published: 2021
Journal Articles

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Free
Clinical Trials & Observations
Bijal D. Shah, Michael R. Bishop, Olalekan O. Oluwole, Aaron C. Logan, Maria R. Baer, William B. Donnellan, Kristen M. O’Dwyer, Houston Holmes, Martha L. Arellano, Armin Ghobadi, John M. Pagel, Yi Lin, Ryan D. Cassaday, Jae H. Park, Mehrdad Abedi, Januario E. Castro, Daniel J. DeAngelo, Adriana K. Malone, Raya Mawad, Gary J. Schiller, John M. Rossi, Adrian Bot, Tong Shen, Lovely Goyal, Rajul K. Jain, Remus Vezan, William G. Wierda
Journal: Blood
Blood (2021) 138 (1): 11–22.
https://doi.org/10.1182/blood.2020009098
Published: 2021
Includes: Supplemental data
Journal Articles

Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study

Free
Farhad Ravandi, MBBS, Asad Bashey, MD PhD, Wendy Stock, MD, James M. Foran, MD, Raya Mawad, MD, Daniel Egan, MD, William Blum, MD, Allen Yang, MD PhD, Alessandro Pastore, MD, Chelsea Johnson, BSN,RN, Shuo Zheng, Musa Yilmaz, MD, Alice S. Mims, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-134746
Published: 2020
Journal Articles

Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Free
Neil Bailey, MSc, Tenzin Tsomo, BS, Jennie Szeto, BA, William I Bensinger, MD, Daniel Egan, MD, Livia Hegerova, MD, Raya Mawad, MD, Ami Batchelder, PA, Joanna Fesler, ARNP, Heather Holdread, MS,NP, Sonia Glennie, ARNP, Judson Hall, ARNP, Joey Ferry, ARNP, Megumi Bailey, MSc, David Kane, RN, John M. Pagel, MDPhD, Krish Patel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-141074
Published: 2020
Journal Articles

The Efficacy of Passive Valve Antimicrobial Swab Caps Against Existing Clabsi Prevention Bundle in an Adult Hematology Inpatient Population: A Quality Improvement Initiative

Free
Joseph F. Ferry, Neil Bailey, MSc, Vanessa Dunleavy, ARNP, Joanna Fesler, ARNP, Judson Hall, PA-C, Sonia Glennie, ARNP, William I Bensinger, MD, Raya Mawad, MD, Krish Patel, MD, Daniel Egan, MD, John M. Pagel, MDPhD, Livia Hegerova, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-143299
Published: 2020
Journal Articles

Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study

Free
Farhad Ravandi, MD, Asad Bashey, MD PhD, James M. Foran, MD, Wendy Stock, MD, Raya Mawad, MD, William Blum, MD, M. Wayne Saville, MD, Chelsea M. Johnson, BSN, K. Gary J. Vanasse, MD, Thomas Ly, PhD, Hagop M. Kantarjian, MD, Bhavana Bhatnagar, DO, Koichi Takahashi, MD, Alice S. Mims, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 763.
https://doi.org/10.1182/blood-2018-99-119786
Published: 2018